<code id='6DC3EB116E'></code><style id='6DC3EB116E'></style>
    • <acronym id='6DC3EB116E'></acronym>
      <center id='6DC3EB116E'><center id='6DC3EB116E'><tfoot id='6DC3EB116E'></tfoot></center><abbr id='6DC3EB116E'><dir id='6DC3EB116E'><tfoot id='6DC3EB116E'></tfoot><noframes id='6DC3EB116E'>

    • <optgroup id='6DC3EB116E'><strike id='6DC3EB116E'><sup id='6DC3EB116E'></sup></strike><code id='6DC3EB116E'></code></optgroup>
        1. <b id='6DC3EB116E'><label id='6DC3EB116E'><select id='6DC3EB116E'><dt id='6DC3EB116E'><span id='6DC3EB116E'></span></dt></select></label></b><u id='6DC3EB116E'></u>
          <i id='6DC3EB116E'><strike id='6DC3EB116E'><tt id='6DC3EB116E'><pre id='6DC3EB116E'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:7998

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          focus

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?
          Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Roche drug slashes death risk in early

          Roche'sboothatthe2023ESMOconference.AndrewJoseph/STATMADRID—ARochedrugloweredtheriskofrecurrenceorde